Teva Slams Eli Lilly's 'Free Ride' On Migraine IP As Trial Opens
IP Law 360
OCTOBER 19, 2022
Teva Pharmaceuticals kicked off its migraine drug patent infringement trial against Eli Lilly and Co. on Wednesday, telling a Boston federal jury that the rival shouldn't be allowed to "free ride" on its hard-won research to rake in sales for a similar treatment.
Let's personalize your content